Younger age and shorter chronic phase in b2a2-positive chronic myeloid leukemia adults with high white blood cell count at diagnosis [6]

Haematologica

Volumn 87, Issue 6, 2002, Pages 666-668

  Martinez Mancilla, Manuel ^a   Gutiérrez, Mario ^a   De la Rosa, Gildardo Zafra ^a   Garcia Carrancá, Alejandro ^a   Gariglio, Patricio ^a   Miranda, Enrique ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Age; Bcr abl; Chronic myeloid leukemia

Indexed keywords

BCR ABL PROTEIN; BIOLOGICAL MARKER; RNA;

ADULT; ARTICLE; BONE MARROW BIOPSY; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION PROCESS; ADOLESCENT; AGE DISTRIBUTION; AGED; GENE REARRANGEMENT; GENETICS; LETTER; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BIOLOGICAL MARKERS; FEMALE; FUSION PROTEINS, BCR-ABL; GENE REARRANGEMENT; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKOCYTE COUNT; MALE; MIDDLE AGED; RNA, NEOPLASM;

EID: 0036282898     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Chronic myelogenous leukemia and related disorders
2. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining
3. The molecular biology of chronic myeloid leukemia
4. Chronic myelogenous leukaemia
5. The diversity of Bcr-Abl fusion proteins and their relationship to leukemia phenotype
6. Detection by polymerase chain reaction of bcr/abl transcripts in myeloproliferative diseases at time of diagnosis and for monitoring chronic myelogenous leukaemia patients after bone marrow transplantation
7. Analysis of molecular breakpoint and mRNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: No correlation with clinical features, cytogenetic response, duration of chronic phase, or survival
8. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
9. Prognostic discrimination in good-risk chronic granulocytic leukemia